MedTrace Logo

Project VerioVue Enhancements - Arterial Study

NCT06121856 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2023-11-08

No results posted yet for this study

Summary

The aim of this performance evaluation is to compare the blood glucose results obtained using the VerioVue Blood Glucose Monitoring System (BGMS) with those obtained from a validated comparator method (iSTAT 1 Analyser) using arterial blood. The main question the study aims to answer is:

How accurate is the VerioVue BGMS when compared to a product that has already been confirmed as accurate (iSTAT 1 Analyser) when hospital staff test arterial blood on these two types of instrument? Participants will have a small amount of blood taken from an existing arterial line.

Conditions

Interventions

DEVICE

VerioVue Enhancements BGMS

Blood glucose monitoring system

Sponsors & Collaborators

  • LifeScan Scotland Ltd

    lead INDUSTRY

Principal Investigators

  • Nicola Zammitt, MBChB · Edinburgh Centre for Endocrinology and Diabetes

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-07
Primary Completion
2023-04-28
Completion
2023-04-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121856 on ClinicalTrials.gov